Bioinspired Antimicrobial Strategy: An Extremophile Deep Sea Peptide to Combat Cystic Fibrosis Infections Caused by <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i>.

Mar Drugs · 2026 · PMC13208616 · PMID 42188299

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Compared with untreated infected larvae, treatment with ALV at 10 mg/kg resulted in a modest increase in survival that did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Bioinspired Antimicrobial Strategy: An Extremophile Deep Sea Peptide to Combat Cystic Fibrosis Infections Caused by &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; and &lt;i&gt;Staphylococcus aureus&lt;/i&gt;.

The sentences

Bioinspired Antimicrobial Strategy: An Extremophile Deep Sea Peptide to Combat Cystic Fibrosis Infections Caused by <i>Pseudomonas aeruginosa</i> and <i>Staphylococcus aureus</i>.